Literature DB >> 16945594

Endocrine correlates of acute nausea and vomiting.

Bärbel Otto1, Rudolf L Riepl, Sibylle Klosterhalfen, Paul Enck.   

Abstract

This paper gives an overview of studies investigating endocrine changes in acute nausea and vomiting. The aetiology of nausea and vomiting is not fully understood, but it has been shown that different stress hormones are released into circulation during motion sickness. Studies with animals and humans have shown that acute nausea activates the hypothalamo-pituitary-adrenal axis and the neurohypophyseal system. So-called stress hormones, like adrenocorticotropic hormone, cortisol, and antidiuretic hormone, are released concomitant with nausea and vomiting in motion sickness, but do not seem to be involved in the aetiology of motion sickness. Nevertheless, plasma levels of stress hormones more or less correlate to the intensity of nausea related symptoms. Although gastroenteropancreatic hormones are involved in gastrointestinal motility, there are only few data describing their changes in response to acute nausea or vomiting.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16945594     DOI: 10.1016/j.autneu.2006.07.010

Source DB:  PubMed          Journal:  Auton Neurosci        ISSN: 1566-0702            Impact factor:   3.145


  10 in total

1.  Motion sickness, stress and the endocannabinoid system.

Authors:  Alexander Choukèr; Ines Kaufmann; Simone Kreth; Daniela Hauer; Matthias Feuerecker; Detlef Thieme; Michael Vogeser; Manfred Thiel; Gustav Schelling
Journal:  PLoS One       Date:  2010-05-21       Impact factor: 3.240

Review 2.  Assessing the neuroendocrine stress response in the functional neuroimaging context.

Authors:  Anthony P King; Israel Liberzon
Journal:  Neuroimage       Date:  2009-05-27       Impact factor: 6.556

3.  Ondansetron blocks LiCl-induced conditioned place avoidance but not conditioned taste/flavor avoidance in rats.

Authors:  Linda Rinaman; Mitra Saboury; Elizabeth Litvina
Journal:  Physiol Behav       Date:  2009-07-05

Review 4.  Cannabinoid Hyperemesis Syndrome: A Review of Potential Mechanisms.

Authors:  Marieka V DeVuono; Linda A Parker
Journal:  Cannabis Cannabinoid Res       Date:  2020-06-05

5.  Cannabidiol Interferes with Establishment of Δ9-Tetrahydrocannabinol-Induced Nausea Through a 5-HT1A Mechanism.

Authors:  Marieka V DeVuono; Olivia La Caprara; Gavin N Petrie; Cheryl L Limebeer; Erin M Rock; Matthew N Hill; Linda A Parker
Journal:  Cannabis Cannabinoid Res       Date:  2020-12-21

6.  Anti-nausea effects and pharmacokinetics of ondansetron, maropitant and metoclopramide in a low-dose cisplatin model of nausea and vomiting in the dog: a blinded crossover study.

Authors:  Hannah Kenward; Jonathan Elliott; Terry Lee; Ludovic Pelligand
Journal:  BMC Vet Res       Date:  2017-08-16       Impact factor: 2.741

7.  Storage of passive motion pattern in hippocampal CA1 region depends on CaMKII/CREB signaling pathway in a motion sickness rodent model.

Authors:  Junqin Wang; Jiluo Liu; Leilei Pan; Ruirui Qi; Peng Liu; Wei Zhou; Yiling Cai
Journal:  Sci Rep       Date:  2017-02-23       Impact factor: 4.379

8.  Sex and Age Differences in Motion Sickness in Rats: The Correlation with Blood Hormone Responses and Neuronal Activation in the Vestibular and Autonomic Nuclei.

Authors:  Wei Zhou; Junqin Wang; Leilei Pan; Ruirui Qi; Peng Liu; Jiluo Liu; Yiling Cai
Journal:  Front Aging Neurosci       Date:  2017-02-15       Impact factor: 5.750

9.  Stroboscopic lighting with intensity synchronized to rotation velocity alleviates motion sickness gastrointestinal symptoms and motor disorders in rats.

Authors:  Yuqi Mao; Leilei Pan; Wenping Li; Shuifeng Xiao; Ruirui Qi; Long Zhao; Junqin Wang; Yiling Cai
Journal:  Front Integr Neurosci       Date:  2022-07-28

10.  Nausea-Induced Conditioned Gaping Reactions in Rats Produced by High-Dose Synthetic Cannabinoid, JWH-018.

Authors:  Marieka V DeVuono; Kelly M Hrelja; Gavin N Petrie; Cheryl L Limebeer; Erin M Rock; Matthew N Hill; Linda A Parker
Journal:  Cannabis Cannabinoid Res       Date:  2020-12-15
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.